Housing scheme for endosulfan victims

Dubai, Jun 9: A young NRI engineer in Dubai, who supported his pregnant spouse to file a plea in the Supreme Court of India for early repatriation from the UAE amid the coronavirus lockdown passed away in his sleep of suspected cardiac arrest.

The deceased identified as Nithin Chandran (28) and his wife Athira Geetha Sreedharan (27) had hit headlines in the past after the latter filed a writ petition seeking assistance to be repatriated to India, following the suspension of flights to the country, as she was due for the delivery of their first baby in the first week of July.

Chandran, a mechanical engineer was working at a construction firm in Dubai. According to the reports, he had stayed back in UAE after sending his wife home on the first day of repatriation from Dubai on May 7 under the Vande Bharat Mission.

The deceased was receiving the treatment for high blood pressure and a heart condition and is suspected to have died of a heart attack while asleep, his friend said. However, the exact cause of his death is yet to be known.

Mangaluru, Apr 23: An elderly woman who was tested positive for COVID-19 in Dakshina Kannada district today breathed her last.

The deceased is a 77-year-old woman from Bantwal taluk. 

She is said to be a close relative of the Bantwal woman who died of COVID-19 on April 19.

She was shifted to govt Wenlock Hospital which is now converted into COVID-19 hospital on April 22 from a private hospital.

Her throat swabs were sent for testing. Health and family welfare department earlier today confirmed that she was tested positive for coronavirus.

Within hours she breathed her last without responding to any treatment. 

So far 17 corona positive cases have been confirmed in the district including two deaths. Most of them have returned home after recovering.

New Delhi, Jun 11: The Department of Pharmaceuticals has given its nod for lifting of ban on the export of hydroxychloroquine, Union Minister D V Sadananda Gowda said on Wednesday.

India had banned export of hydroxychloroquine on March 25, with some exceptions, amid views in some quarters that the drug could be used to fight COVID-19. On April 4, it completely banned the exports without any exception.

"Department of Pharmaceuticals has approved the lifting of ban on export of Hydroxychloroquine API as well as formulations. Manufacturers except SEZ/EOU Units have to supply 20 per cent production in the domestic market," the minister of chemicals and fertilisers said in a tweet.

The Directorate General of Foreign Trade (DGFT) has been asked to issue formal notification in this regard, he added.

In another tweet, Gowda said he held discussions with representatives of pharma companies along with some of his ministerial colleagues on the challenges being faced by the industry and on the roadmap to boost exports.

"Had detailed discussion with representatives of pharma companies & association, stakeholder Ministries along with Hon Ministers @piyushGoyal  ji, @HardeepSPuri  ji, & @MansukhMandviya  ji on entire gamut of challenges faced by the industry as well as strategies to boost pharma export," Gowda tweeted.

India exported hydroxychloroquine API (active pharmaceutical ingredient) worth USD 1.22 billion in April-January 2019-20.

During the same period, exports of formulations made from hydroxychloroquine was at USD 5.50 billion.